These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

123 related items for PubMed ID: 1462022

  • 41. Addition of anticholinergic solution prolongs bronchodilator effect of beta 2 agonists in patients with chronic obstructive pulmonary disease.
    Levin DC, Little KS, Laughlin KR, Galbraith JM, Gustman PM, Murphy D, Kram JA, Hardie G, Reuter C, Ostransky D, McFarland K, Petty TL, Silvers W, Rennard SI, Mueller M, Repsher LH, Zuwallack RL, Vale R.
    Am J Med; 1996 Jan 29; 100(1A):40S-48S. PubMed ID: 8610716
    [Abstract] [Full Text] [Related]

  • 42. The effect of aerosol ipratropium bromide and salbutamol on exercise tolerance in chronic bronchitis.
    Leitch AG, Hopkin JM, Ellis DA, Merchant S, McHardy GJ.
    Thorax; 1978 Dec 29; 33(6):711-3. PubMed ID: 154748
    [Abstract] [Full Text] [Related]

  • 43. Tiotropium bromide, a new long-acting antimuscarinic bronchodilator: a pharmacodynamic study in patients with chronic obstructive pulmonary disease (COPD). Dutch Study Group.
    Maesen FP, Smeets JJ, Sledsens TJ, Wald FD, Cornelissen PJ.
    Eur Respir J; 1995 Sep 29; 8(9):1506-13. PubMed ID: 8575576
    [Abstract] [Full Text] [Related]

  • 44. Ipratropium bromide hydrofluoroalkane inhalation aerosol is safe and effective in patients with COPD.
    Taylor J, Kotch A, Rice K, Ghafouri M, Kurland CL, Fagan NM, Witek TJ, Ipratropium Bromide HFA Study Group.
    Chest; 2001 Oct 29; 120(4):1253-61. PubMed ID: 11591569
    [Abstract] [Full Text] [Related]

  • 45. Bronchodilator reversibility to low and high doses of terbutaline and ipratropium bromide in patients with chronic obstructive pulmonary disease.
    Newnham DM, Dhillon DP, Winter JH, Jackson CM, Clark RA, Lipworth BJ.
    Thorax; 1993 Nov 29; 48(11):1151-5. PubMed ID: 8296260
    [Abstract] [Full Text] [Related]

  • 46. The effect of ipratropium bromide on nasal hypersecretion induced by methacholine in patients with vasomotor rhinitis. A double-blind, cross-over, placebo-controlled and randomized dose-response study.
    Sjögren I, Jonsson L, Köling A, Jansson C, Osterman K, Håkansson B.
    Acta Otolaryngol; 1988 Nov 29; 106(5-6):453-9. PubMed ID: 2974675
    [Abstract] [Full Text] [Related]

  • 47. Comparative dose-response study of three anticholinergic agents and fenoterol using a metered dose inhaler in patients with chronic obstructive pulmonary disease.
    Ikeda A, Nishimura K, Koyama H, Izumi T.
    Thorax; 1995 Jan 29; 50(1):62-6. PubMed ID: 7886652
    [Abstract] [Full Text] [Related]

  • 48. Effects of theophylline and ipratropium bromide on exercise performance in patients with stable chronic obstructive pulmonary disease.
    Tsukino M, Nishimura K, Ikeda A, Hajiro T, Koyama H, Izumi T.
    Thorax; 1998 Apr 29; 53(4):269-73. PubMed ID: 9741369
    [Abstract] [Full Text] [Related]

  • 49. The inhaled bronchodilators ipratropium bromide and metaproterenol in adults with CF.
    Weintraub SJ, Eschenbacher WL.
    Chest; 1989 Apr 29; 95(4):861-4. PubMed ID: 2522385
    [Abstract] [Full Text] [Related]

  • 50. Inhaled formoterol dry powder versus ipratropium bromide in chronic obstructive pulmonary disease.
    Dahl R, Greefhorst LA, Nowak D, Nonikov V, Byrne AM, Thomson MH, Till D, Della Cioppa G, Formoterol in Chronic Obstructive Pulmonary Disease I Study Group.
    Am J Respir Crit Care Med; 2001 Sep 01; 164(5):778-84. PubMed ID: 11549532
    [Abstract] [Full Text] [Related]

  • 51. The effect of high doses of inhaled salbutamol and ipratropium bromide in patients with stable cystic fibrosis.
    Sanchez I, De Koster J, Holbrow J, Chernick V.
    Chest; 1993 Sep 01; 104(3):842-6. PubMed ID: 8365299
    [Abstract] [Full Text] [Related]

  • 52. Ipratropium bromide inhalation for allergic rhinitis and chronic cough.
    Shore SC, Weinberg EG.
    S Afr Med J; 1981 Feb 21; 59(8):252. PubMed ID: 6451037
    [No Abstract] [Full Text] [Related]

  • 53. Efficacy of salmeterol xinafoate in the treatment of COPD.
    Mahler DA, Donohue JF, Barbee RA, Goldman MD, Gross NJ, Wisniewski ME, Yancey SW, Zakes BA, Rickard KA, Anderson WH.
    Chest; 1999 Apr 21; 115(4):957-65. PubMed ID: 10208192
    [Abstract] [Full Text] [Related]

  • 54. A placebo-controlled comparison between the bronchodilatory effects of ipratropium bromide inhaled as a dry powder and by metered dose inhaler in chronic obstructive pulmonary disease.
    Gimeno F, van Veenen R, Berg WC, Steenhuis EJ.
    Ann Allergy; 1988 Nov 21; 61(5):341-3. PubMed ID: 2973269
    [Abstract] [Full Text] [Related]

  • 55. The influence of ipratropium bromide in the recovery phase of methacholine induced-bronchospasm.
    Sposato B, Mariotta S, Ricci A, Bruno P, Terzano C, Mannino F.
    Eur Rev Med Pharmacol Sci; 2005 Nov 21; 9(2):117-23. PubMed ID: 15945501
    [Abstract] [Full Text] [Related]

  • 56. A meta-analysis of the effects of ipratropium bromide in adults with acute asthma.
    Rodrigo G, Rodrigo C, Burschtin O.
    Am J Med; 1999 Oct 21; 107(4):363-70. PubMed ID: 10527039
    [Abstract] [Full Text] [Related]

  • 57. A double-blind crossover study comparing the safety and efficacy of three weeks of Flu/Sal 250/50 bid plus albuterol 180 ug prn q4 hours to Flu/Sal 250/50 bid plus albuterol/Ipratropium bromide 2 puffs prn q4 hours in patients with chronic obstructive pulmonary disease.
    Balkissoon R, Make B.
    COPD; 2008 Aug 21; 5(4):221-7. PubMed ID: 18671147
    [Abstract] [Full Text] [Related]

  • 58. Effects of ipratropium bromide and fenoterol aerosols in pulmonary emphysema.
    Hughes JA, Tobin MJ, Bellamy D, Hutchison DC.
    Thorax; 1982 Sep 21; 37(9):667-70. PubMed ID: 6218647
    [Abstract] [Full Text] [Related]

  • 59. The additive effect of theophylline on a high-dose combination of inhaled salbutamol and ipratropium bromide in stable COPD.
    Nishimura K, Koyama H, Ikeda A, Sugiura N, Kawakatsu K, Izumi T.
    Chest; 1995 Mar 21; 107(3):718-23. PubMed ID: 7874943
    [Abstract] [Full Text] [Related]

  • 60. Spirometric correlates of improvement in exercise performance after anticholinergic therapy in chronic obstructive pulmonary disease.
    O'Donnell DE, Lam M, Webb KA.
    Am J Respir Crit Care Med; 1999 Aug 21; 160(2):542-9. PubMed ID: 10430726
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.